Over the past 12 months, $INBX has been discussed by two distinct FinTwit voices, with Jacob Plieth (@jacobplieth) contributing four mentions and Adam Feuerstein (@adamfeuerstein) contributing one mention. The first mention appeared on November 6, 2025, and the most recent activity occurred on May 8, 2026. Discussion has centered on clinical trial safety data and upcoming results for the company's cancer programs.